x

Society

Pfizer and Paxlovid Anti-viral Drugs for Covid-19 Available from Monday

ATHENS – The anti-viral drugs for Covid-19 Nirmtrelvir and Ritonavir, produced by Paxlovid and Pfizer, will be available in Greece from Monday, while applications for the drug can start to be submitted from Friday. The procedure will be similar to that used for the drug produced by Lagevrio.

The drug can be administered in the first five days after symptoms appear and applications are submitted in the first three days after symptoms appear and are confirmed by a Covid test. The patient must be registered for e-prescriptions as the drug can only be prescribed via an online platform.

RELATED

ATHENS – In a world filled with challenges, art stands as a beacon of hope, capable of transforming lives.

Top Stories

Columnists

A pregnant woman was driving in the HOV lane near Dallas.

General News

NEW YORK – Meropi Kyriacou, the new Principal of The Cathedral School in Manhattan, was honored as The National Herald’s Educator of the Year.

Video

Over 100 Pilot Whales Beached on Western Australian Coast Have Been Rescued, Officials Say

MELBOURNE, Australia (AP) — More than 100 long-finned pilot whales that beached on the western Australian coast Thursday have returned to sea, while 29 died on the shore, officials said.

A television host recently asked me: “Donald Trump is revered by so many and reviled by so many others.

As we head toward the culmination of the divine drama and the celebration of Holy Pascha, this special time is prime for sharpening our spiritual senses, but also contemplating certain qualities of our cultural otherness that shape our worldview and unique historical standpoint.

ATHENS – In a world filled with challenges, art stands as a beacon of hope, capable of transforming lives.

To the Editor: It is something incredible, and I will convey my appreciation with great excitement and admiration.

Enter your email address to subscribe

Provide your email address to subscribe. For e.g. [email protected]

You may unsubscribe at any time using the link in our newsletter.